第一工業製薬(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証PRM | 化学 | 4461/E00885 | - |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2022/05/27 | 日証協 | 33,546株 | +7.5% | 3,540株 | -81.56% | 55,664株 | +2.58% | 12,998株 | +419.92% |
| 2022/05/20 | 日証協 | 31,206株 | +15.55% | 19,200株 | +481.82% | 54,264株 | -7.81% | 2,500株 | +19.05% |
| 2022/05/13 | 日証協 | 27,006株 | +16.88% | 3,300株 | +153.85% | 58,864株 | +12.41% | 2,100株 | -58% |
| 2022/05/06 | 日証協 | 23,106株 | -16.39% | 1,300株 | +128.47% | 52,364株 | -7.59% | 5,000株 | -34.22% |
| 2022/04/28 | 日証協 | 27,637株 | -5.47% | 569株 | -87.63% | 56,664株 | +1.98% | 7,601株 | -49.32% |
| 2022/04/22 | 日証協 | 29,237株 | +12.29% | 4,600株 | +24.32% | 55,562株 | +12.33% | 14,999株 | +51.46% |
| 2022/04/15 | 日証協 | 26,037株 | +16.03% | 3,700株 | -77.3% | 49,461株 | +1.64% | 9,903株 | +76.87% |
| 2022/04/08 | 日証協 | 22,440株 | -33.61% | 16,300株 | +17.27% | 48,661株 | -35.31% | 5,599株 | -85.44% |
| 2022/04/01 | 日証協 | 33,800株 | +0.3% | 13,900株 | -17.54% | 75,218株 | +0.94% | 38,460株 | +178.74% |
| 2022/03/25 | 日証協 | 33,700株 | -18.04% | 16,856株 | +3271.2% | 74,521株 | -5.89% | 13,798株 | -23.33% |
| 2022/03/18 | 日証協 | 41,119株 | -18.6% | 500株 | -97.01% | 79,183株 | +12.5% | 17,997株 | -42.68% |
| 2022/03/11 | 日証協 | 50,516株 | +19.38% | 16,700株 | +1291.67% | 70,386株 | +49.8% | 31,399株 | +234.1% |
| 2022/03/04 | 日証協 | 42,316株 | -26.68% | 1,200株 | -89.47% | 46,986株 | -8.21% | 9,398株 | -36.92% |
| 2022/02/25 | 日証協 | 57,716株 | +9.9% | 11,400株 | +43% | 51,186株 | +11.31% | 14,899株 | +80.64% |
| 2022/02/18 | 日証協 | 52,516株 | +4.58% | 7,972株 | -10.43% | 45,986株 | +13.44% | 8,248株 | -22.48% |
| 2022/02/10 | 日証協 | 50,216株 | +14.35% | 8,900株 | +71.15% | 40,536株 | +5.19% | 10,640株 | +18.25% |
| 2022/02/04 | 日証協 | 43,916株 | -5.06% | 5,200株 | +52.94% | 38,536株 | -2.63% | 8,998株 | +1.55% |
| 2022/01/28 | 日証協 | 46,256株 | -10.11% | 3,400株 | -46.03% | 39,575株 | +1.54% | 8,861株 | -25.53% |
| 2022/01/21 | 日証協 | 51,456株 | +3.42% | 6,300株 | +293.75% | 38,975株 | +10.18% | 11,898株 | +1.7% |
※株式分割は考慮していませんのでご注意ください。
Page Top